GI / PPI · General Oral/Topical
UXARO-L
Rabeprazole 20 mg + Levosulpiride 75 mg
Manufactured at WHO-GMP certified facility by BIOFRIL HEALTHCARE. Available for hospital tender supply, ICU pharmacy, and PCD franchise distribution across India.
Product Specifications
UXARO-L at a Glance
| Brand Name | UXARO-L |
|---|---|
| Composition | Rabeprazole 20 mg + Levosulpiride 75 mg |
| Therapeutic Category | GI / PPI |
| Division | General Oral/Topical |
| Pack / Presentation | Cap. 10*10 ALU-ALU |
| Manufacturer | BIOFRIL HEALTHCARE Pvt. Ltd. · WHO-GMP Plant, Nalagarh HP |
Clinical Use
Indications & Clinical Applications
UXARO-L (Rabeprazole 20 mg + Levosulpiride 75 mg) is indicated for the treatment of conditions in which Rabeprazole 20 mg therapy is clinically appropriate. For complete prescribing information please refer to the official product insert.
Get PCD Franchise Price List — UXARO-L
Share your details — our franchise team will call you back with the product list, franchise rates and monopoly-area availability for your district.